Eupalinolide I derivative EJM alleviates experimental hyperuricemia through STAT1-associated regulation of intestinal inflammation and gut microbiota

Lilin Yan, Zhimin Zhu, Yuanjian Xu, Yudong Lin, Zhaohui Xu, Mingmei Zhou

Open source

DOI
10.1093/jpp/rgag140
Published
2026-11
Container
Journal of Pharmacy and Pharmacology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jpp/rgag140,
  title = {Eupalinolide I derivative EJM alleviates experimental hyperuricemia through STAT1-associated regulation of intestinal inflammation and gut microbiota},
  author = {Lilin Yan and Zhimin Zhu and Yuanjian Xu and Yudong Lin and Zhaohui Xu and Mingmei Zhou},
  year = {2026},
  journal = {Journal of Pharmacy and Pharmacology},
  doi = {10.1093/jpp/rgag140},
  url = {https://doi.org/10.1093/jpp/rgag140}
}

RIS

TY  - JOUR
TI  - Eupalinolide I derivative EJM alleviates experimental hyperuricemia through STAT1-associated regulation of intestinal inflammation and gut microbiota
AU  - Lilin Yan
AU  - Zhimin Zhu
AU  - Yuanjian Xu
AU  - Yudong Lin
AU  - Zhaohui Xu
AU  - Mingmei Zhou
PY  - 2026
JO  - Journal of Pharmacy and Pharmacology
DO  - 10.1093/jpp/rgag140
UR  - https://doi.org/10.1093/jpp/rgag140
ER  - 

APA

Yan, L., Zhu, Z., Xu, Y., Lin, Y., Xu, Z., & Zhou, M. (2026). Eupalinolide I derivative EJM alleviates experimental hyperuricemia through STAT1-associated regulation of intestinal inflammation and gut microbiota. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgag140

Source records